Navigation Links
Clazosentan May help to Improve Blood Circulation after Brain Hemorrhage due to burst Aneurysm

A study published in the July edition of the Journal of Neurosurgery suggests that Clazosentan can reduce the // number and severity of cases of constriction of blood vessels (called vasospasm) following aneurysmal subarachnoid haemorrhage (SAH).

Normally constriction of blood vessels occurs approx. 5-14 days following a SAH and this leads to strokes and neurological deficits. This can cause not only significant disability but is also a major cause of death.

Patients on the drug also develop fewer cerebral infarcts. Dr Peter Vajkoczy, Neurosurgeon at the Department of Neurosurgery, University Hospital, Mannheim, and the main author of the study comments: "While our understanding of cerebral vasospasm has continued to improve, a solution to this challenge is yet to be found. However, these results are certainly promising and it is important that these findings are assessed and confirmed in a larger population to identify how clazosentan may have an impact in clinical practice."

Dr Neal Kassell, Professor and Co-chairman of the Department of Neurological Surgery at the University of Virginia comments: "It is encouraging to finally, after nearly one-half century of futile investigations, be able to introduce into clinical trials an agent that, based on experimental studies, has a real potential for preventing vasospasm and, based on preliminary clinical studies, appears to be without significant side effects (including hypotension), as well as exhibiting a suggestion of efficacy."

Over a quarter of people die within the first week following an aneurysmal subarachnoid haemorrhage without treatment. Re-bleeding occurs in 50% of the aneurysms within the first six months, and about half of patients die after a rebleed and a further 20% become disabled.

For further info contact: Actelion contact: Alan Archer Global Product Communications manager Actelion Ltd Gewerbestrasse 16 CH-4123 Allschwil Switz erland 41-79-289-8083 http://www.actelion.com
'"/>




Related medicine news :

1. Hypertensive Drug Improves Sexual Dysfunction in Hypertensive Men
2. Steps To Improve Quality Of Plant-Based Drugs
3. Almonds Improve Cholesterol
4. How to Improve Life Expectancy
5. Sage Improves Memory
6. Protein said to Improve Muscle Loss
7. Ultrasound Screening Could Improve The Outcome Of Critically ill Patients
8. New Drug Combination Found To Improve Memory in Alzheimer’s Patient
9. Vitamin B12 Supplements Found To Improve Memory
10. A Loving Relationship Found To Improve Heart Health
11. Fish Found To Improve Fetal Growth
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... ... March 28, 2017 , ... Oily skin is a common and unwelcomed occurrence in people of ... a lot to offer to the discussion of dealing with excess skin oil. “Oily skin ... many home remedies that can help remove the oily shine while keeping the skin fresh ...
(Date:3/28/2017)... ... March 28, 2017 , ... “A Prophets Bones”: a thrilling adventure that reveals the ... , “There were things that his parents and teachers had asked of him that he ... he was going to defy the Almighty Creator. There were some who would have felt ...
(Date:3/27/2017)... FL (PRWEB) , ... March 27, 2017 , ... ... new patients for clear braces. People who want straight teeth without the extensive ... Invisalign® in Clearwater, FL, without acquiring a referral. A custom-designed series of ...
(Date:3/27/2017)... ... 2017 , ... Drs. Justin Kolnick, Kara Diamond, Randall Barton, Keith Hope and ... key role this treatment plays in protecting oral health, along with the benefits of ... who need a root canal in White Plains, NY or their second location in ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... A study ... Buckingham MD, and his colleague, Sudeep Roy, MD, was recently published in the ... Electrocautery Efficacy in Rhytidectomy” details Drs. Buckingham and Roy’s study on the use of ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 2017  Sanderling Ventures, portfolio company, Torax Medical, ... of Johnson & Johnson. Torax manufactures and markets the ... gastro-esophageal reflux disease (GERD). The LINK device is ... the procedure is currently available in the U.S. ... was founded by Sanderling Ventures, Mayo Medical Ventures ...
(Date:3/27/2017)... TEL AVIV, Israel , March 27, 2017 ... focused on oncology and immunology, announced today that AGI-134, an ... recently announced acquisition of Agalimmune Ltd., will be featured at ... Meeting in Washington, DC to ... ...
(Date:3/27/2017)... , March 27, 2017 The ... reach USD 16.0 billion by 2025, according to a ... prevalence of chronic diseases is anticipated to be responsible ... which thereby widens the scope for growth during the ... bariatric population, which is highly susceptible to chronic diseases, ...
Breaking Medicine Technology: